MDDI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Supplier Stories for the Week of October 7

Here’s what was new in the world of medical device suppliers during the week of October 7.

  • This is a compilation of the latest news from suppliers in the medical device industry.

    If you have news you’d like to submit for potential inclusion in this weekly roundup, please send a press release and any related images to [email protected] with the subject line “Supplier Stories.”


  • After working together on many projects over the years, Resonetics and Meraqi Medical have formed a strategic alliance to support development and commercialization of technically challenging devices. The two independent companies focus on high-growth segments such as bioelectronics, interventional, structural heart, and neurovascular applications and have helped support miniaturization requirements. Meraqi offers design, development, and finished device assembly expertise, while Resonetics provides component and sub-assembly manufacturing capabilities. 

    “We have embraced innovation and speed as critical components to our success,” said Tom Burns, president & CEO at Resonetics, in a news release. “Meraqi has a similar mantra and with this strategic alliance, we will now make it easier for our customers to access proven design, development, and manufacturing capabilities. We know how important speed to market and design for manufacturability are to our customers and they will appreciate the innovative and customer centric approach at Meraqi.” 

    Al Hershey, CEO of Meraqi Medical, added: “Meraqi Medical is a young company, but our team has decades of experience dedicated to helping companies advance their technologies to market.”

    “Partnering with best-in-class suppliers allows us to advance our customers’ projects quickly and efficiently. Our team has a passion for innovation while also putting a high value on being flexible and easy to work with and our alliance with Resonetics addresses both attributes,” added Julie Schulte, president, Meraqi Medical.

    Attendees of MD&M Minneapolis are invited to meet Schulte at Booth #1940 October 31 from 10 to 11:30 am.

    [Image courtesy of MERAQI MEDICAL]

  • SYNEO has redesigned and upgraded its ACCU-BLAST automated microblasting equipment line to increase robustness and maintainability. For instance, the CRS100 now features a Comco AccuFlo micro-abrasive blaster, newly designed internal Pinch Roll Feeders (PRF), and in-line inspection options. The system includes integrated outside diameter (OD) measurement and average roughness (Ra) surface measurement, pass/fail binning, fully programmable application recipes, and made-to-order tooling to handle a range of diameters, patterns, and inspection criteria for wire ablation and surface roughening applications. 

    “This system exemplifies several advantages that SYNEO can bring to our customers,” stated Crew Feighery, SYNEO VP of business development, in a news release. “In an environment where customers look to automate manual feeding processes while improving application resolution and quality inspection outcomes, SYNEO’s ability to leverage its feeding, inspection and control technology can greatly improve the chances of success.” 

    [Image courtesy of SYNEO]

  • West Pharmaceutical Services Inc. has introduced a new Integrated Solutions Program to help reduce risk, mitigate regulatory complexity, and simplify development of drug containment and delivery system solutions. 

    ”Our customers are under increasing pressure to move new therapies to market quickly while maintaining cost efficiencies – all while enduring increased regulatory scrutiny,” said Karen Flynn, SVP & Chief Commercial Officer, West, in a statement. ”West’s new Integrated Solutions Program will allow our customers to efficiently leverage our extensive knowledge of primary containment and delivery systems and advanced analytical testing capabilities to manage the regulatory landscape while helping to reduce development and supply risk, accelerate path to market, minimize total cost of ownership, and improve the patient experience.”

    At CPhI Worldwide, the company introduced Daikyo’s D Sigma stoppers available in Ready-to-Use-Validated (RUV) and Ready-to-Sterilize-Validated (RSV) formats. The components offer the tightest particulate specification in the Daikyo portfolio and 100 percent dimensional verification, helping to reduce variability and mitigate potential risks to patient safety.

    In addition, West received the 2018 Excellence in Pharma: Corporate Social Responsibility Award during CPhI Worldwide.


  • Gintzler International has upgraded its quality management system registration to ISO 13485:2016. The company is a narrow web label, shrink sleeve, and flexible packaging printer and converter serving the medical and pharmaceutical, health and beauty, food and beverage, and consumer goods markets.

    “ISO 13485 has continued to evolve in ways that enhance quality, risk analysis, and the focus on listening to our customers. We have upgraded our procedures to match the new requirements and successfully completed our audit to the new standard,” said Dan Rozanski, general manager of Gintzler International – NY, in a statement.

    The new ISO 13485 uses a risk management approach in all processes of the quality management system, the company stated.  Other major changes include:

    • Validation of the computer software used in the quality management system.
    • New requirements for complaint-handling processes.
    • Definition of the required competence of personnel involved in quality management documentation and verification of the effectiveness of training measures.

    “Our recent upgrade of this widely-recognized ISO quality standard represents the culmination of significant effort by our entire team,” stated Rozanski. “This latest company achievement is an essential part of the organization’s strategy and a testament to our on-going commitment to provide label and package identification solutions to clients in the medical and pharmaceutical markets.”

    [Logo courtesy of GINTZLER INTERNATIONAL]

  • M5 Shielded and Overmoulded Cable Connectors, part of Binder USA’s 707 Series, were developed for the miniature sensor market. The connectors feature 360-degree shielding with non-disrupted data transfer because of screening attenuation values from 60 dB in the 1 GHz range. A threaded nut that is immune to vibration. 

    Features include:

    • Number of contacts: 3 or 4.
    • Cable lengths: 2 m or 5 m.
    • IP67 rated.
    • Rated voltage: 60.
    • Rated current: 1 A.
    • Temperature range: -25°C to 80°C.
    • Housing material: PUR.
    • Contact plating: Au.
    • Custom configurations available.

    [Image courtesy of BINDER USA]

Daphne Allen

Daphne Allen is editor-in-chief of MD+DI. She previously served as executive editor of Pharmaceutical & Medical Packaging News, which serves as the pharmaceutical and medical device channel of Packaging Digest. Daphne has covered medical device manufacturing, packaging, labeling, and regulatory issues as well as pharmaceutical packaging and labeling for more than 20 years. She is also a member of the Institute of Packaging Professionals's Medical Device Packaging Technical Committee. Follow her on Twitter at @daphneallen.


500 characters remaining